Kicking Off the Cancer Planners Forum in Geneva – UICC
oncodaily - Union for International Cancer Control (UICC) shared a post on LinkedIn: “We’re excited to kick off the Cancer Planners Forum in Geneva today! Convening national leaders responsible for cancer control planning, […]
AI Summary: The UICC Cancer Planners Forum in Geneva brought policymakers, clinicians, and public‑health leaders together to map national cancer control strategies, prioritize cervical cancer elimination, and foster implementation partnerships. The forum emphasized practical planning, stakeholder engagement, and resource‑sensitive solutions to turn plans into measurable improvements in prevention, screening, and care delivery.
- Cervical cancer elimination and clinical partnerships (3)
- Forum launch and wrap-up in Geneva (3)
- National cancer planning and policy priorities (3)
- All Other Stories
Cervical cancer elimination and clinical partnerships
Forum launch and wrap-up in Geneva
National cancer planning and policy priorities
All Other Stories
Women’s experiences are forgotten in research on childbirth and breastfeeding
Thomas Saïas, Professeur de psychologie, Université du Québec à Montréal (UQAM) / theconversation - Two studies in the field of perinatal care show how, in the areas of breastfeeding and obstetrics, science prioritizes risk and the baby at the expense of mothers’ well-being.
AI Summary: New analyses show that research into childbirth and breastfeeding repeatedly sidelines women's firsthand experiences, prioritizing clinical metrics over lived realities. Experts warn this gap limits understanding of postpartum challenges, skews policy and perpetuates poorer care. Calls are growing for qualitative measures, patient-centered outcomes and inclusive study designs that actually listen to mothers.
- Clinical and policy focus on fetus over mothers' care (3)
- Mothers’ experiences ignored in childbirth and breastfeeding research (4)
- Women’s pain and reproductive conditions dismissed by medicine (4)
- All Other Stories
Clinical and policy focus on fetus over mothers' care
Mothers’ experiences ignored in childbirth and breastfeeding research
Women’s pain and reproductive conditions dismissed by medicine
All Other Stories
License to deliver: Some midwives break the law to assist with home births
medicalxpress - In a midwife's suburban Atlanta home with a playground and chicken coop outside, Madie Collins lay on an examination table while the midwife measured her pregnant belly. Unlike at many a doctor's office, no crinkly paper sheet covered the table and no ant…
AI Summary: A growing number of midwives are reportedly supporting planned home births outside legal frameworks, knowingly operating without required licences. Regulators and health systems face a tricky balance between enforcing safety standards and meeting demand for community-based birthing options. Expect investigations, heated debates, and at least one bureaucrat suddenly very busy.
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
Cyril Erameh / nature - Nature Medicine, Published online: 15 May 2026; doi:10.1038/s41591-026-04402-wAn open-label, randomized controlled phase 2 trial comparing favipiravir with ribavirin for the treatment of mild-to-moderate Lassa fever in Nigeria found that favipiravir was s…
AI Summary: An open-label, randomized Phase 2 trial of favipiravir for Lassa fever reported encouraging results, suggesting antiviral benefit where few options exist. The study offers early clinical proof-of-concept, especially important for endemic West African settings, and calls for larger trials to confirm efficacy, optimize dosing, and assess deployment logistics.
US drug overdose deaths fall for 3rd straight year: 5 notes
Kristin Kuchno / beckershospitalreview - An estimated 69,973 Americans died of drug overdoses in the 12-month period ending December 2025, a 13.9% decline from the previous year and the third consecutive year that figure has dropped, according to CDC data published May 13. The decline marks the …
AI Summary: Provisional data show U.S. drug-overdose deaths fell for the third straight year, marking a welcome dip in a long-running crisis. Public-health experts caution the improvement masks shifting drug supplies, regional variation and policy gaps, urging sustained prevention, treatment access and surveillance to avoid backsliding.
PCOS has been officially renamed PMOS, and it’s a momentous move
newscientist - PCOS will now be known as PMOS (polyendocrine metabolic ovarian syndrome), and for Alice Klein, who has the conditon, it's been a long time coming
AI Summary: Medical experts have rebranded polycystic ovary syndrome as "polyendocrine metabolic ovarian syndrome" (PMOS) to better reflect its metabolic and endocrine drivers and improve diagnosis and treatment for about 170 million affected women worldwide. The change follows years of debate over an inaccurate name and aims to reduce misdiagnosis and guide more targeted care—because calling it something sensible might actually help.
Healthcare bankruptcies increased 33% in Q1: 6 things to know
Andrew Cass / beckershospitalreview - Healthcare Chapter 11 bankruptcy filings rose to 12 cases in the first quarter of 2026, up from 9 cases in the fourth quarter of 2025, according to an April report by Gibbins Advisors. The report analyzed Chapter 11 bankruptcy filings with liabilities of …
AI Summary: A new report finds healthcare bankruptcies rose 33% in the first quarter, underscoring mounting financial pressure across providers from squeezed margins, rising expenses and a tricky reimbursement environment. The surge raises concerns about patient access, consolidation and creditor fallout, and suggests policymakers and executives may need to stop pinching pennies and start fixing structural problems.
- Budgeting, Labor and Management Fixes Under Strain (5)
- Closures, Downgrades and State Rescue Responses (4)
- Q1 Bankruptcy Surge: Numbers and Sector Breakdown (3)
- All Other Stories
Budgeting, Labor and Management Fixes Under Strain
Closures, Downgrades and State Rescue Responses
Q1 Bankruptcy Surge: Numbers and Sector Breakdown
All Other Stories
With Commissioner Under Pressure, F.D.A. Opens Door to Flavored Vapes
Christina Jewett / nytimes - Though illicit e-cigarettes have flooded in from China, the new policy could allow major tobacco companies to sell from prime shelf space at thousands of stores.
AI Summary: Facing mounting pressure, the FDA has signaled authorization of fruit‑flavored vaping products for adults, a regulatory shift framed as adult access and harm reduction. Public‑health experts warn the move risks increasing youth appeal and reignites debate over flavors, enforcement, and whether potential population‑level tradeoffs were adequately considered.
Delays in visa program threaten doctor placements in underserved areas
medicalxpress - Hundreds of foreign doctors about to complete training in the U.S. will have to leave the country if the federal government doesn't rapidly process their visa waiver applications, which have been languishing since the fall and winter, immigration attorney…
AI Summary: Delays and backlogs in the physician visa program are jeopardizing placement of hundreds of doctors destined for underserved communities, leaving health systems scrambling to fill gaps. Hospitals warn patient access and care continuity could suffer as credentialing and onboarding timelines stretch, forcing local providers to shoulder heavier loads.
WakeMed Health's plans to join Atrium Health face swift pushback from NC officials
fiercehealthcare - A combination unveiled May 1 would bring WakeMed Health $2 billion in promised investment from the major nonprofit system. State officials voiced concerns about the impact of such consolidation and the value of those commitments, delaying a planned go-ahe…
AI Summary: Atrium Health’s plan to fold WakeMed into its system — backed by a roughly $2 billion investment plan — is running into immediate resistance from North Carolina officials. State leaders and local stakeholders have raised concerns about consolidation, competition and community impact, threatening regulatory scrutiny that could delay or reshape the deal. Expect tense negotiations, press statements and a few dramatic headlines.
US may lose measles elimination status after outbreaks spread to 45 states
medicalxpress - After public health experts declared measles eliminated in the U.S. in 2000, the U.S. Centers for Disease Control and Prevention (CDC) established seven indicators of measles elimination status to ensure that the country remained on track. Now, analyzing …
AI Summary: Widespread measles outbreaks now touch dozens of states, raising alarms that the US could lose its measles elimination status. Public health teams warn of falling immunity, rising transmission, and the urgent need for vaccination campaigns, while unconventional signals—like prediction markets—are drawing attention as noisy but sometimes useful outbreak indicators.
- Detection and science: markets, sequencing, and treatments (3)
- Threat to U.S. measles elimination and spread drivers (4)
- Vaccine hesitancy, framing, safety, and delivery capacity (4)
- All Other Stories
Detection and science: markets, sequencing, and treatments
Threat to U.S. measles elimination and spread drivers
Vaccine hesitancy, framing, safety, and delivery capacity
All Other Stories
Court restricts abortion access across US by blocking mailing of mifepristone
abcnews - A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone
AI Summary: A federal appeals court has imposed new limits on distribution of mifepristone, blocking mail-order shipments and narrowing telehealth-based prescribing. The decision immediately complicates access for patients and clinicians who rely on remote care and pharmacy delivery, forcing last‑minute logistical changes, increased travel, and swift legal and policy responses as providers scramble to adapt.
- Appeals court halts mail and telehealth access (4)
- Clinical pivots and drug alternatives amid disruptions (3)
- Supreme Court temporarily restores mail access (5)
- All Other Stories
Appeals court halts mail and telehealth access
Clinical pivots and drug alternatives amid disruptions
Supreme Court temporarily restores mail access
All Other Stories
U.S. Government Will Stop Paying for Test Strips to Detect Deadly Drugs
Jan Hoffman / nytimes - In a letter to states and other grant recipients, the Trump administration says the strips encourage drug use.
AI Summary: Public health officials have declared the South Carolina measles outbreak over after nearly 1,000 people fell ill, attributing containment to intensified vaccination campaigns and contact tracing. Authorities warn that immunity gaps still exist and stressed that preventable outbreaks will recur without sustained immunization efforts — a blunt reminder that vaccines remain the easiest way to avoid headline-making contagions.
Cigna exits ACA exchanges despite dramatic profit growth in Q1
Rebecca Pifer Parduhn / healthcaredive - The insurer plans to say goodbye to the ACA exchanges after this year, and is exploring a potential sale of its controversial claims review subsidiary. Both businesses were more trouble than they were worth, executives said.
AI Summary: Cigna announced it will withdraw from Affordable Care Act individual exchanges even after reporting robust first-quarter earnings. The insurer cites strategic and operational reasons for exiting markets where risk and costs bite, a move likely to reduce competition in some states and could leave consumers with fewer plan choices or higher premiums.
WHO approves first malaria treatment for infants
medicalxpress - The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.
AI Summary: The World Health Organization has cleared the first malaria treatment specifically for infants, granting prequalification that paves the way for broader procurement and use in endemic countries. Regulators' sign-off targets a vulnerable age group long underserved by effective pediatric therapies, potentially speeding distribution through global health channels and donor programs.
Distribution of Phase I lung cancer trials may be consolidating at top-performing US sites
medicalxpress - Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly concentrated at the top 20 highest-volume clinical trial si…
AI Summary: A new analysis shows Phase I lung cancer trials are becoming concentrated at a relatively small number of leading U.S. centers, raising concerns about geographic inequity in access to early‑phase studies. The trend could speed drug development at elite sites while leaving patients in other regions with fewer experimental options and longer travel burdens.
- Conference highlights, care models and awareness (4)
- Consolidation at top U.S. Phase I centers (3)
- Early-phase trials and next-gen therapies (4)
- All Other Stories
Conference highlights, care models and awareness
Consolidation at top U.S. Phase I centers
Early-phase trials and next-gen therapies
All Other Stories
UK passes bill that will eventually ban cigarette purchases
abcnews - Parliament has passed a bill to make cigarettes inaccessible to future generations in the U.K. Children born after December 31, 2008, will never be able to buy cigarettes under the new Tobacco and Vapes Bill
AI Summary: The UK has passed legislation phasing out tobacco sales for younger generations, effectively banning cigarette purchases for people born after 2008. The law creates a rolling age‑based prohibition aimed at cutting smoking initiation and long‑term health harms, while stirring debate over enforcement, retail impact and the practicalities of turning childhood prevention into adult policy.
- Explainers and advocacy for the Tobacco and Vapes Bill (4)
- Health context: cancer burden and treatment equity (3)
- Parliament approves smoking ban for future generations (4)
- All Other Stories
Explainers and advocacy for the Tobacco and Vapes Bill
Health context: cancer burden and treatment equity
Parliament approves smoking ban for future generations
All Other Stories
340B drug discounts are drifting from patients to profit, and reform is now on the table
medicalxpress - The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking behaviors, says the American College of Physicians (ACP). In a new policy, "Reforming 340B to Promote Program Integrity and Better Serv…
AI Summary: The 340B drug-discount program is under renewed scrutiny after analyses and advocacy groups argue discounts intended to help patients are instead boosting institutional margins. Hospitals, provider groups and the AHA are contesting HRSA proposals and court rulings, sparking policy debates and potential regulatory fixes to curb markups and steer savings back to vulnerable patients.
FDA updates mifepristone safety study status
Ella Jeffries / beckershospitalreview - The FDA updated its mifepristone guidance, detailing ongoing work on a safety study and the current status of the drug’s Risk Evaluation and Mitigation Strategy program. According to an April 8 news release, the agency said it is still collecting and eval…
AI Summary: The FDA updated the safety review status for mifepristone, yet the regulatory change hasn’t translated into widespread retail availability. Many community pharmacies are still hesitant to dispense the drug due to logistical, legal and reputational concerns, leaving access limited despite federal moves intended to broaden distribution — so yes, policy changed, but practice lagged.
'I'm not being listened to' - new health plan launched as women say they are still ignored
bbc - New plans to improve healthcare for women and girls have been set out, but will they change anything?
AI Summary: Health officials unveiled a new women's health plan, but many women say the rollout feels performative and that their concerns remain unheard. Patient advocates warn the initiative risks repeating past mistakes unless it embeds lived experience, transparent accountability and genuine co-design—otherwise it's policy theater with a glossy brochure.